APA (7th ed.) Citation

R, D. (2026). Letter: Beyond Survival Benefit in CHANCE2311-Important Considerations in the Interpretation of TACE Combined With Immunotherapy in Advanced HCC. Authors' Reply. Alimentary pharmacology & therapeutics. https://doi.org/10.1111/apt.70803

Chicago Style (17th ed.) Citation

R, Ding. "Letter: Beyond Survival Benefit in CHANCE2311-Important Considerations in the Interpretation of TACE Combined With Immunotherapy in Advanced HCC. Authors' Reply." Alimentary Pharmacology & Therapeutics 2026. https://doi.org/10.1111/apt.70803.

MLA (9th ed.) Citation

R, Ding. "Letter: Beyond Survival Benefit in CHANCE2311-Important Considerations in the Interpretation of TACE Combined With Immunotherapy in Advanced HCC. Authors' Reply." Alimentary Pharmacology & Therapeutics, 2026, https://doi.org/10.1111/apt.70803.